An amperometric glucose biosensor based on the direct electron transfer of glucose oxidase (GOx) was developed by electrochemically entrapping GOx onto the inner wall of highly ordered polyaniline nanotubes (nanoPANi), which was synthesized using anodic aluminum oxide (AAO) membrane as a template. The cyclic voltammetric results indicated that GOx immobilized on the nanoPANi underwent direct electron transfer reaction, and the cyclic voltammogram displayed a pair of well-defined and nearly symmetric redox peaks with a formal potential of -405 +/- 5 mV and an apparent electron transfer rate constant of 5.8 +/- 1.6 s(-1). The biosensor had good electrocatalytic activity toward oxidation of glucose and exhibited a rapid response (approximately 3 s), a low detection limit (0.3 +/- 0.1 microM), a useful linear range (0.01-5.5 mM), high sensitivity (97.18 +/- 4.62 microA mM(-1) cm(-2)), higher biological affinity (the apparent Michaelis-Mentan constant was estimated to be 2.37 +/- 0.5 mM) as well as good stability and repeatability. In addition, the common interfering species, such as ascorbic acid, uric acid, and 4-acetamidophenol, did not cause any interference due to the use of a low detection potential (-0.3 V vs SCE). The biosensor can also be used for quantification of the concentration of glucose in real clinical samples.

No abstract

To achieve the electrochemical nitrogen reduction reaction (NRR) for efficient and sustainable NH3 production, catalysts should exhibit high selectivity and activity with optimal adsorption energy. Herein we developed a three‐dimensional (3D) amorphous BiNi alloy toward a significantly enhanced NRR compared with its crystalline and metal counterparts. Ni alloying enables the chemisorption of nitrogen and the lower free‐energy change for the *NNH formation, and the 3D alloy electrocatalyst exhibits high catalytic activity for NH3 production with a yield rate of 17.5 μg h−1 mgcat−1 and Faradaic efficiency of 13.8 %. The enhanced electron transfer and increased electrochemical surface area were revealed in the interconnected porous scaffold, affording it sufficiently efficient and stable activity for potential practical applications. This work offers new insights into optimizing the adsorption energy of reactants and intermediates combined with tuning the crystallinity of NRR electrocatalysts.

This work develops and validates an electrochemical approach for uric acid (UA) determinations in both endogenous (cell lysate) and physiological (serum) samples. This approach is based on the electrocatalytic reduction of enzymatically generated H(2)O(2) at the biosensor of uricase-thionine-single-walled carbon nanotube/glassy carbon (UOx-Th-SWNTs/GC) with the use of Th-SWNTs nanostructure as a mediator and an enzyme immobilization matrix. The biosensor, which was fabricated by immobilizing UOx on the surface of Th-SWNTs, exhibited a rapid response (ca. 2 s), a low detection limit (0.5 +/- 0.05 microM), a wide linear range (2 microM to 2 mM), high sensitivity (approximately 90 microA mM(-1) cm(-2)), as well as good stability and repeatability. In addition, the common interfering species, such as ascorbic acid, 3,4-dihydroxyphenylacetic acid, 4-acetamidophenol, etc., did not cause any interference due to the use of a low operating potential (-400 mV vs saturated calomel electrode). Therefore, this work has demonstrated a simple and effective sensing platform for selective detection of UA in the physiological levels. In particular, the developed approach could be very important and useful to determine the relative role of endogenous and physiological UA in various conditions such as hypertension and cardiovascular disease.